GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soligenix Inc (LTS:0A6I) » Definitions » Payments of Debt

Soligenix (LTS:0A6I) Payments of Debt : $-0.69 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Soligenix Payments of Debt?

Soligenix's Payments of Debt for the three months ended in Sep. 2024 was $-0.69 Mil.

Soligenix's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.69 Mil.


Soligenix Payments of Debt Historical Data

The historical data trend for Soligenix's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soligenix Payments of Debt Chart

Soligenix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 -0.01 - -7.00

Soligenix Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -0.69

Soligenix Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Soligenix Payments of Debt Related Terms

Thank you for viewing the detailed overview of Soligenix's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Soligenix Business Description

Traded in Other Exchanges
Address
29 Emmons Drive, Suite B-10, Princeton, NJ, USA, 08540
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Soligenix Headlines

No Headlines